Special Issue "Autism Spectrum Disorder: From Etio-Pathology to Treatment"
A special issue of Brain Sciences (ISSN 2076-3425).
Deadline for manuscript submissions: closed (15 September 2017).
Dr. Pushpal Desarkar
Medical Head, Adult Neurodevelopmental Services, Centre for Addiction and Mental Health; Clinician-Scientist, Temerty Centre for Therapeutic Intervention and Assistant Professor of Psychiatry, University of Toronto, Toronto, Ontario, Canada
Website | E-Mail
Interests: Autism Spectrum Disorder; brain stimulation; neurophysiology; neuroscience; psychopharmacology
Autism Spectrum Disorder (ASD) is the most common neurodevelopmental disorder. Almost seven decades have passed since Leo Kanner’s original description of the condition, yet the cause of ASD is still unknown and there is no identified cure. Since the turn of the century, significant advancements have been made in ASD research, and a range of macro- and micro-structural, neurochemical, functional, anatomic, and genetic abnormalities have been proposed. Findings emerging from these research studies have started to influence intervention research more than ever over the past couple of decades.
In this exciting Special Issue on “Autism Spectrum Disorder: From Etio-Pathology to Treatment”, we would like to invite manuscripts on different translational pathways between research conducted on ‘etio-pathology’ and ‘mechanism-driven treatment’ in ASD. We are specifically requesting submission of papers on a diverse topics related to ‘etio-pathology’, e.g., neuroimaging, neuroanatomy, genetics, neurophysiology, neuropathology, etc and ‘treatment’, e.g., pharmacological, brain stimulation, non-pharmacological, such as behavioral, sensory, and psychological intervention, etc. Authors are advised that submissions with an etiological focus should have a translational emphasis and submissions with a treatment focus should be neurobiologically informed. As such, the scope is quite broad and works in both basic science and clinical science are welcome.
Dr. Pushpal Desarkar
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Autism Spectrum Disorder
- Translational Research
- Novel Treatment